1. Home
  2. G vs AMRX Comparison

G vs AMRX Comparison

Compare G & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genpact Limited

G

Genpact Limited

N/A

Current Price

$39.45

Market Cap

6.8B

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$21.47

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
G
AMRX
Founded
1997
2002
Country
Bermuda
United States
Employees
140000
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.4B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
G
AMRX
Price
$39.45
$21.47
Analyst Decision
Buy
Strong Buy
Analyst Count
12
7
Target Price
★ $42.91
$23.43
AVG Volume (30 Days)
1.7M
★ 3.1M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 1.93%
N/A
EPS Growth
9.82
★ 157.89
EPS
★ 1.71
0.37
Revenue
★ $2,279,438,000.00
N/A
Revenue This Year
$7.02
$4.73
Revenue Next Year
$7.08
$9.36
P/E Ratio
★ $22.68
$57.64
Revenue Growth
N/A
N/A
52 Week Low
$26.85
$10.68
52 Week High
$48.64
$21.68

Technical Indicators

Market Signals
Indicator
G
AMRX
Relative Strength Index (RSI) 61.79 66.49
Support Level $32.99 $16.59
Resistance Level $41.84 N/A
Average True Range (ATR) 1.24 0.61
MACD 0.15 0.12
Stochastic Oscillator 65.31 88.95

Price Performance

Historical Comparison
G
AMRX

About G Genpact Limited

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: